| MTERF1 — Mitochondrial Transcription Termination Factor 1 | |
|---|---|
| Symbol | MTERF1 |
| Full Name | Mitochondrial Transcription Termination Factor 1 |
| Chromosome | 7q21.3 |
| NCBI Gene | 5101 |
| Ensembl | ENSG00000138442 |
| OMIM | 605350 |
| UniProt | P56183 |
| Diseases | [Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers), Mitochondrial Disorders |
| Expression | High in brain, heart, skeletal muscle (mitochondrial) |
Mterf1 Gene Mitochondrial Transcription Termination Factor 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
MTERF1 (Mitochondrial Transcription Termination Factor 1), also known as MTERF, is a gene located on chromosome 7q21.3 that encodes a mitochondrial DNA-binding protein essential for mitochondrial gene expression[1]. MTERF1 plays a critical role in regulating mitochondrial transcription and has been implicated in neurodegenerative diseases due to the central role of mitochondrial dysfunction in these conditions[2].
The MTERF1 gene spans approximately 11 kb of genomic DNA on chromosome 7q21.3 and consists of 2 exons. The gene encodes a 399 amino acid protein that localizes to mitochondria. MTERF1 is part of a family of mitochondrial transcription termination factors that includes MTERF2, MTERF3, and MTERF4 in mammals[3].
MTERF1 is a mitochondrial protein that regulates transcription of mitochondrial DNA (mtDNA):
In neurons, MTERF1 is particularly important due to the high energy demands of these cells. Mitochondrial function is essential for:
Mitochondrial dysfunction is a central feature of Parkinson's Disease pathogenesis:
Mitochondrial dysfunction is also prominent in AD:
MTERF1 mutations have been associated with:
MTERF1 and mitochondrial transcription represent therapeutic targets for neurodegenerative diseases:
Mterf1 Gene Mitochondrial Transcription Termination Factor 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Mterf1 Gene Mitochondrial Transcription Termination Factor 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.